Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications multinational drug utilisation study investigate use dexmedetomidine dexdor�� clinical 1
… IG, Barnett CL, Mladsi DM Transcript: The Institute for Clinical and Economic Review, or ICER, is an independent, … the value of health technologies in the US. In a recent study, the majority of payers interviewed reported they would use an ICER cost-effectiveness threshold price as a basis for …
… and participation in the National Birth Defects Prevention Study. Ms. Saltus’ prior research includes studies of cocaine … epidemiologic support for the preparation of orphan drug applications and other key regulatory submissions in the … large-scale projects and coordinated multidisciplinary, multinational project teams. Recent projects at RTI-HS …
… in the field of pharmacoepidemiology. His experience and publications span a wide range of substantive areas, … diseases, and pregnancy, and incorporate multidatabase and multinational studies. He has been a project leader or … clinical and public health audiences about observational study design, large database utilization, and propensity …
… models (cost effectiveness, budget impact) Drug utilization studies Economic burden of illness studies …
… Research Analyst for the Mississippi Evidence-based Drug Utilization Review (MS-DUR) Initiative at the University … decision-making and inform evidence-based appropriate use of medication in the Mississippi Medicaid population. Dr. … comparative effectiveness and health policy research and investigate patient-reported outcomes. Dr. Korgaonkar is …
… product and disease, along with specific questions on clinical and economic issues for HTA for up to 3 specific … studies. This helps in implementing appropriate study design for both regulatory and HTA purposes. However, …
… decade has seen an increased focus on patient-centered drug development. Product labeling based on patient-reported … (PRO) endpoints are therefore of special interest to drug manufacturers. The Patient-Centered Outcomes Assessment … FDA PRO labeling over the past ten years. The resulting study, A Review of Patient-Reported Outcome Labeling in the …
… 2022 American Society of Clinical Psychopharmacology (ASCP) Share on: Tuesday, May 31 … will be presented at the 2022 American Society of Clinical Psychopharmacology. Risk of mortality associated …
… health illnesses. Our experience includes: Alcohol and drug abuse and dependence Anxiety disorders, including Acute … models (cost effectiveness, budget impact, Markov) Drug utilization studies Economic burden of illness studies …
… States. It allows Medicare to negotiate prescription drug prices with manufacturers and put an inflation cap on … As of now, the answer is yes — they will . Joint Clinical Assessments/Joint Scientific Consultations Joint … that address high unmet medical needs as well as the use of comparative, rather than single arm, clinical trials. …